Clinical trial
Hookworm Therapy for Coeliac Disease: A Phase 1B Safety and Dose-ranging Clinical Trial Examining Sustained Gluten Consumption in Hookworm-naive and Hookworm-infection People With Coeliac Disease
NCT02754609 is registered in ClinicalTrials.gov with James Cook University, Queensland, Australia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hookworm Therapy for Coeliac Disease: A Phase 1B Safety and Dose-ranging Clinical Trial Examining Sustained Gluten Consumption in Hookworm-naive and Hookworm-infection People With Coeliac Disease
- Lead sponsor
- James Cook University, Queensland, Australia
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2016
- Completion date
- October 31, 2019
- Enrollment
- 54 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.